Logo - International Journal of Pharmaceutical Compounding

Gender Bias in the Treatment of Menopausal Women: I am Hot as Hell and Not Going to Take It Anymore, Part 1

Author(s):  DeRosa Angela

Issue:  Nov/Dec 2020 - Volume 24, Number 6
View All Articles in Issue

Abstract:  Gender bias within hormone replacement therapy has been prevalent for decades, and the circumstances surrounding this bias continue to worsen. A billion-dollar industry has been built on dozens of testosterone replacement therapies and medications to treat andropause and erectile dysfunction for men; women have been less fortunate. This article discusses this bias and the well-orchestrated attempt by the pharmaceutical industry to eliminate bioidentical hormones, as well as to downplay the important role of compounding pharmacies in fulfilling the needs of women in this longstanding gender gap.

Related Keywords: Angela DeRosa, DO, MBA, CPE, hormone replacement therapy, HRT, bioidentical hormone replacement therapy, compounded bioidentical hormone therapy, cBHT, National Academies of Science, Engineering and Medicine, NASEM, women, testosterone replacement, hormone gender gap, libido, sex drive, gender bias, psychotropic drugs, antidepressants, androgen therapy, North American Menopause Society, NAMS, Endocrine Society, pharmaceutical industry, pharma


Purchase this article for download in electronic PDF format from IJPC at for $35 at:

Search the entire IJPC archive by keyword, topic, or issue at: